Is ADPT or ADVB more undervalued in 2026?

CirclFi compares Adaptive Biotechnologies Corpor (ADPT) and Advanced Biomed Inc. (ADVB) using 13 institutional-grade valuation models. ADPT has a Quality of Company score of 7.6/10 while ADVB scores 5.7/10.

Which is a better buy — ADPT or ADVB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ADPT and ADVB valuations compare?

ADPT at $15.19 and ADVB at $3.91 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ADPT vs ADVB Valuation Comparison 2026 — Intrinsic Value Analysis

ADPT

Diagnostics & Research

Adaptive Biotechnologies Corpor

Quality

7.6

out of 10

Value Trap

LOW

Price

$15.19

Last close

Models

13/13

Active

ADVB

Diagnostics & Research

Advanced Biomed Inc.

Quality

5.7

out of 10

Value Trap

—

Price

$3.91

Last close

Models

5/13

Active

Model-by-Model Comparison

Model	Type	ADPT Fair Value	ADPT Upside	ADVB Fair Value	ADVB Upside
Bayesian DCF	Intrinsic	$2.98	-80.4%	$20.02	+411.9%
Earnings Power Value	Intrinsic	$2.29	-83.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.89	-94.1%	$3.46	-11.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADPT vs ADVB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADPT vs ADVB — Which Stock Is More Undervalued?

ADPT scores higher with a 7.6/10 quality rating vs ADVB's 5.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Adaptive Biotechnologies Corpor (ADPT) and Advanced Biomed Inc. (ADVB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADPT currently trades at $15.19 with a QOC of 7.6/10, while ADVB trades at $3.91 with a QOC of 5.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).